Cargando…

Age Dependency of the Prognostic Impact of Tumor Genomics in Localized Resectable MYCN-Nonamplified Neuroblastomas. Report From the SIOPEN Biology Group on the LNESG Trials and a COG Validation Group

For localized, resectable neuroblastoma without MYCN amplification, surgery only is recommended even if incomplete. However, it is not known whether the genomic background of these tumors may influence outcome. PATIENTS AND METHODS: Diagnostic samples were obtained from 317 tumors, International Neu...

Descripción completa

Detalles Bibliográficos
Autores principales: Ambros, Inge M., Tonini, Gian-Paolo, Pötschger, Ulrike, Gross, Nicole, Mosseri, Véronique, Beiske, Klaus, Berbegall, Ana P., Bénard, Jean, Bown, Nick, Caron, Huib, Combaret, Valérie, Couturier, Jerome, Defferrari, Raffaella, Delattre, Olivier, Jeison, Marta, Kogner, Per, Lunec, John, Marques, Barbara, Martinsson, Tommy, Mazzocco, Katia, Noguera, Rosa, Schleiermacher, Gudrun, Valent, Alexander, Van Roy, Nadine, Villamon, Eva, Janousek, Dasa, Pribill, Ingrid, Glogova, Evgenia, Attiyeh, Edward F., Hogarty, Michael D., Monclair, Tom F., Holmes, Keith, Valteau-Couanet, Dominique, Castel, Victoria, Tweddle, Deborah A., Park, Julie R., Cohn, Sue, Ladenstein, Ruth, Beck-Popovic, Maja, De Bernardi, Bruno, Michon, Jean, Pearson, Andrew D. J., Ambros, Peter F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605396/
https://www.ncbi.nlm.nih.gov/pubmed/32903140
http://dx.doi.org/10.1200/JCO.18.02132